Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 784

1.

Directly Converted Human Fibroblasts Mature to Neurons and Show Long-Term Survival in Adult Rodent Hippocampus.

Avaliani N, Pfisterer U, Heuer A, Parmar M, Kokaia M, Andersson M.

Stem Cells Int. 2017;2017:5718608. doi: 10.1155/2017/5718608. Epub 2017 Nov 26.

2.

The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening.

Gonzalez DM, Gregory J, Brennand KJ.

Front Cell Dev Biol. 2017 Dec 19;5:117. doi: 10.3389/fcell.2017.00117. eCollection 2017. Review.

3.

Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles.

Chang JH, Tsai PH, Wang KY, Wei YT, Chiou SH, Mou CY.

Sci Rep. 2018 Jan 8;8(1):11. doi: 10.1038/s41598-017-18324-8.

4.

Neuronal replacement therapy: previous achievements and challenges ahead.

Grade S, Götz M.

NPJ Regen Med. 2017 Oct 23;2:29. doi: 10.1038/s41536-017-0033-0. eCollection 2017. Review.

5.

Heart regeneration for clinical application update 2016: from induced pluripotent stem cells to direct cardiac reprogramming.

Yamakawa H.

Inflamm Regen. 2016 Oct 24;36:23. doi: 10.1186/s41232-016-0028-z. eCollection 2016. Review.

6.

Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling.

Brumbaugh J, Di Stefano B, Wang X, Borkent M, Forouzmand E, Clowers KJ, Ji F, Schwarz BA, Kalocsay M, Elledge SJ, Chen Y, Sadreyev RI, Gygi SP, Hu G, Shi Y, Hochedlinger K.

Cell. 2018 Jan 11;172(1-2):106-120.e21. doi: 10.1016/j.cell.2017.11.023. Epub 2017 Dec 14.

PMID:
29249356
7.

Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming.

Ruetz T, Pfisterer U, Di Stefano B, Ashmore J, Beniazza M, Tian TV, Kaemena DF, Tosti L, Tan W, Manning JR, Chantzoura E, Ottosson DR, Collombet S, Johnsson A, Cohen E, Yusa K, Linnarsson S, Graf T, Parmar M, Kaji K.

Cell Stem Cell. 2017 Dec 7;21(6):791-805.e9. doi: 10.1016/j.stem.2017.10.013. Epub 2017 Nov 22.

8.

Engineering new neurons: in vivo reprogramming in mammalian brain and spinal cord.

Wang LL, Zhang CL.

Cell Tissue Res. 2018 Jan;371(1):201-212. doi: 10.1007/s00441-017-2729-2. Epub 2017 Nov 23. Review.

PMID:
29170823
9.

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons.

Tang Y, Liu ML, Zang T, Zhang CL.

Front Mol Neurosci. 2017 Nov 2;10:359. doi: 10.3389/fnmol.2017.00359. eCollection 2017.

10.

Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.

Oh J, Kim Y, Che L, Kim JB, Chang GE, Cheong E, Kang SG, Ha Y.

PLoS One. 2017 Nov 21;12(11):e0178881. doi: 10.1371/journal.pone.0178881. eCollection 2017.

11.

Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts.

Sung EA, Yu KR, Shin JH, Seo Y, Kim HS, Koog MG, Kang I, Kim JJ, Lee BC, Shin TH, Lee JY, Lee S, Kang TW, Choi SW, Kang KS.

Oncotarget. 2017 Aug 7;8(49):85428-85441. doi: 10.18632/oncotarget.19976. eCollection 2017 Oct 17.

12.

CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.

Inoue K, Oliveira LMA, Abeliovich A.

Cell Rep. 2017 Nov 14;21(7):1727-1736. doi: 10.1016/j.celrep.2017.10.075.

13.

Direct reprogramming of mouse fibroblasts into neural cells via Porphyra yezoensis polysaccharide based high efficient gene co-delivery.

Yu Q, Chen J, Deng W, Cao X, Wang Y, Zhou J, Xu W, Du P, Wang Q, Yu J, Xu X.

J Nanobiotechnology. 2017 Nov 14;15(1):82. doi: 10.1186/s12951-017-0317-y.

14.

Cell Therapy for Parkinson's Disease.

Yasuhara T, Kameda M, Sasaki T, Tajiri N, Date I.

Cell Transplant. 2017 Sep;26(9):1551-1559. doi: 10.1177/0963689717735411.

15.

The formation of the light-sensing compartment of cone photoreceptors coincides with a transcriptional switch.

Daum JM, Keles Ö, Holwerda SJ, Kohler H, Rijli FM, Stadler M, Roska B.

Elife. 2017 Nov 6;6. pii: e31437. doi: 10.7554/eLife.31437.

16.

Finding MyoD and lessons learned along the way.

Lassar AB.

Semin Cell Dev Biol. 2017 Dec;72:3-9. doi: 10.1016/j.semcdb.2017.10.021. Epub 2017 Nov 1. Review.

PMID:
29097153
17.

Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.

Sagata N, Kato TA, Kano SI, Ohgidani M, Shimokawa N, Sato-Kasai M, Hayakawa K, Kuwano N, Wilson AM, Ishizuka K, Kato S, Nakahara T, Nakahara-Kido M, Setoyama D, Sakai Y, Ohga S, Furue M, Sawa A, Kanba S.

Sci Rep. 2017 Oct 24;7(1):13905. doi: 10.1038/s41598-017-14440-7.

18.

Ready, Set…Poised!: Polycomb target genes are bound by poised RNA polymerase II throughout differentiation.

Rada-Iglesias A.

Mol Syst Biol. 2017 Oct 23;13(10):950. doi: 10.15252/msb.20177968. No abstract available.

19.

Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?

Drouin-Ouellet J, Pircs K, Barker RA, Jakobsson J, Parmar M.

Front Neurosci. 2017 Sep 28;11:530. doi: 10.3389/fnins.2017.00530. eCollection 2017. Review.

20.

Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases.

Adegbola A, Bury LA, Fu C, Zhang M, Wynshaw-Boris A.

Stem Cells Transl Med. 2017 Dec;6(12):2062-2070. doi: 10.1002/sctm.17-0150. Epub 2017 Oct 13. Review.

Supplemental Content

Support Center